Exploring the Heterogeneous Nature of Desmoid Tumors

This year's top ovarian cancer article highlighted gaps in physician knowledge of genetic testing that may affect patient care.

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

A phase 2b trial found vixarelimab rapidly reduced itch and lesion burden in prurigo nodularis, with sustained benefit and a favorable safety profile.

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival.

Experts at SABCS highlighted the aggressive nature of breast cancer in young women, emphasizing tailored management and support strategies.

The FDA approved subcutaneous amivantamab with recombinant human hyaluronidase for EGFR-mutated NSCLC based on the phase 3 PALOMA-3 trial.